关注
Karen Canfell
Karen Canfell
Cancer Council NSW, University of Sydney
在 nswcc.org.au 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Comprehensive control of human papillomavirus infections and related diseases
FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ...
Vaccine 31, H1-H31, 2013
7962013
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ...
The Lancet 395 (10224), 575-590, 2020
6442020
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
Collaborative Group on Epidemiological Studies of Ovarian Cancer
The Lancet 385 (9980), 1835-1842, 2015
4922015
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
K Canfell, JJ Kim, M Brisson, A Keane, KT Simms, M Caruana, EA Burger, ...
The Lancet 395 (10224), 591-603, 2020
4702020
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
KT Simms, J Steinberg, M Caruana, MA Smith, JB Lew, I Soerjomataram, ...
The lancet oncology 20 (3), 394-407, 2019
4312019
The projected timeframe until cervical cancer elimination in Australia: a modelling study
MT Hall, KT Simms, JB Lew, MA Smith, JML Brotherton, M Saville, ...
The Lancet Public Health 4 (1), e19-e27, 2019
4182019
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
3092016
The burden of cervical cancer in China: synthesis of the evidence
JF Shi, K Canfell, JB Lew, YL Qiao
International journal of cancer 130 (3), 641-652, 2012
2072012
Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia
K Canfell, E Banks, AM Moa, V Beral
Medical Journal of Australia 188 (11), 641-644, 2008
2062008
The IARC perspective on cervical cancer screening
V Bouvard, N Wentzensen, A Mackie, J Berkhof, J Brotherton, ...
New England Journal of Medicine 385 (20), 1908-1918, 2021
1982021
Towards the global elimination of cervical cancer
K Canfell
Papillomavirus research 8, 100170, 2019
1972019
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane, K Canfell
The Lancet Public Health 5 (4), e223-e234, 2020
1842020
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National …
JB Lew, KT Simms, MA Smith, M Hall, YJ Kang, XM Xu, M Caruana, ...
The Lancet Public Health 2 (2), e96-e107, 2017
1812017
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort …
HC Kitchener, K Canfell, C Gilham, A Sargent, C Roberts, M Desai, J Peto
Health Technology Assessment (Winchester, England) 18 (23), 1, 2014
1742014
Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case–control study
M Urban, E Banks, S Egger, K Canfell, D O'Connell, V Beral, F Sitas
PLoS medicine 9 (3), e1001182, 2012
1732012
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
JB Lew, DJB St John, XM Xu, MJE Greuter, M Caruana, DR Cenin, E He, ...
The Lancet Public Health 2 (7), e331-e340, 2017
1522017
Modeling preventative strategies against human papillomavirus-related disease in developed countries
K Canfell, H Chesson, SL Kulasingam, J Berkhof, M Diaz, JJ Kim
Vaccine 30, F157-F167, 2012
1412012
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
M Arbyn, M Simon, E Peeters, L Xu, CJLM Meijer, J Berkhof, K Cuschieri, ...
Clinical Microbiology and Infection 27 (8), 1083-1095, 2021
1392021
Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality
K Canfell, F Sitas, V Beral
Medical Journal of Australia 185 (9), 482-486, 2006
1372006
Is it possible to halve the incidence of liver cancer in China by 2050?
JF Shi, M Cao, Y Wang, FZ Bai, L Lei, J Peng, E Feletto, K Canfell, C Qu, ...
International journal of cancer 148 (5), 1051-1065, 2021
1272021
系统目前无法执行此操作,请稍后再试。
文章 1–20